The common T60N polymorphism of thelymphotoxin-a gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome.

Aims/hypothesis: Associations between variations in the lymphotoxin-a gene (LTA) and myocardial infarction, cerebral infarction and type 1 diabetes have previously been reported. We hypothesised that, in its homozygous form, the functional T60N variant of LTA is associated with type 2 diabetes and other features of the metabolic syndrome among Danish Caucasian individuals. Methods: The T60N polymorphism of LTA was genotyped in the population-based Inter99 study cohort (6,514 Caucasian subjects) and in a group of type 2 diabetic patients by analysis of PCR-generated primer extension products using high- throughput chip-based matrix-assisted laser desorption/ionisation time-of-flight mass spectronomy. Results: Comparison of 1,401 diabetic patients with 1,470 matched glucose-tolerant control subjects from the Inter99 cohort revealed that the frequency of the mutant at codon 60 in its homozygous form (N/N genotype) was higher among the diabetic patients than among the control subjects(14.6% [95% CI 12.8-16.5] vs 12.0% [95% CI 10.3-13.7],p=0.048; odds ratio=1 .24). This association was even stronger among the 131 patients with early-onset (diagnosis at 40 years or younger) diabetes (21.4% [95% CI 14.4-28.4] vs 12.0%[95% CI 10.3-13.7], p=0.004 odds ratio= 1.99). Additionally, studies of the metabolic syndrome (as defined by the 1999 World Health Organization criteria) in the Inter99 study cohort revealed that the frequency of the N/N LTA genotype was higher among subjects presenting one or more features of the metabolic syndrome (n=4,425) than among subjects with no characteristics of th is syndrome (n= 1,752)(p=0.026). Conclusions! interpretation: The T60N LTA polymorphism is associated with type 2 diabetes and other features of the metabolic syndrome among Caucasian individuals. [ABSTRACT FROM AUTHOR]